INTRODUCTION
============

Patients with chronic renal failure manifest significant functional alterations of the immune systems^[@b1-kjim-8-2-86-5],[@b2-kjim-8-2-86-5])^. The dominant immunologic defect resides in the cell-mediated immunity which primarily involves T lymphocytes^[@b3-kjim-8-2-86-5]--[@b5-kjim-8-2-86-5])^. Many studies show cutaneous anergy^[@b6-kjim-8-2-86-5])^, prolonged allograft survival^[@b7-kjim-8-2-86-5],[@b8-kjim-8-2-86-5])^, a decreased antibody response to thymus dependent antigens like vaccination with HB virus^[@b9-kjim-8-2-86-5],[@b10-kjim-8-2-86-5])^, influenza virus^[@b11-kjim-8-2-86-5])^, an increased incidence of infection such as mycobacteriosis^[@b12-kjim-8-2-86-5],[@b13-kjim-8-2-86-5])^ and altered tumor surveillance system^[@b14-kjim-8-2-86-5],[@b15-kjim-8-2-86-5])^. This suppressed cellular immunity can be explained by decreased absolute T lymphocyte numbers^[@b16-kjim-8-2-86-5])^, increase in suppressor T cell activity^[@b5-kjim-8-2-86-5])^ and inhibitory effect of uremic serum on lymphocyte blastogenesis^[@b17-kjim-8-2-86-5])^. The mechanism underlying this cellular immune defect in uremia is not well understood yet. The possibility has been raised to explain the immunosuppression associated with chronic renal failure, including an intrinsic defect of uremic effector T lymphocytes^[@b18-kjim-8-2-86-5])^ and/or the presence of an abnormal immunoregulation mediated by regulatory T lymphocytes (such as, helper and suppressor T cells), monocytes or soluble serum factors^[@b19-kjim-8-2-86-5]--[@b22-kjim-8-2-86-5])^.

Recent studies have indicated that clonal expansion of T lymphocytes, after antigen or mitogen triggering, requires the presence of a soluble mediator or interleukin^[@b23-kjim-8-2-86-5])^. In addition, such a factor also appears to be necessary for differentiation of precytotoxic T lymphocytes into cytotoxic T lymphocyte effector cell^[@b24-kjim-8-2-86-5])^. Several lines of evidence support the notion that a single T cell-derived glycoprotein, termed interleukin-2, possesses both activities in humans as well as experimental animals^[@b25-kjim-8-2-86-5],[@b26-kjim-8-2-86-5])^. Moreover, several techniques have been described for growth of human T lymphocytes colonies in soft agar^[@b27-kjim-8-2-86-5]--[@b29-kjim-8-2-86-5])^. Goube de Laforest et al^[@b30-kjim-8-2-86-5])^ have emphasized the role that cell interactions play in T-cell colony formation and have suggested that the three cell population might cooperate in the primary culture of T-cell colonies. As part of the screening of immune function, T-cell colony formation may be an invaluable measure of cell-mediated immunity.

The purpose of this study is to elucidate the nature of altered immune functions seen in uremic patients by studying IL-2 production and T cell colony forming unit in patients with chronic renal failure.

SUBJECTS AND METHODS
====================

1.. Subjects
------------

Ten healthy normal controls and thirty four patients with end stage renal failure were selected from those who gave informed consent to this study at the dialysis centers of Yongdong Severance Hospital and Severance Hospital, Yonsei University Medical Center. Dialytic patients were selected as relatively stable cases receiving dialysis for more than 3 months. They ranged in age from 20 to 55 years. Patients with end stage renal failure were subdivided by three groups; i.e., predialysis group (14 patients), hemodialysis group (11 patients) and CAPD group (9 patients) ([Table 1](#t1-kjim-8-2-86-5){ref-type="table"}). [Table 2](#t2-kjim-8-2-86-5){ref-type="table"} summarizes BUN, creatinine and duration of dialysis recorded at the time of the blood collected.

2.. Methods
-----------

### 1). Isolation of Peripheral Blood Lymphocytes

Lymphocytes were separated from whole heparinized blood on Ficoll-Hypaque density gradient. The cell layer was washed three times in Hanks solution and suspended in mcCoys 5A medium. The final cell counts of suspension were adjusted to 5×10^3^ cells/ul.

### 2). Separation of Culture Supernatant from Isolated Lymphocytes

Separated lymphocytes were floated at 2×10^6^ cells/ml in final culture medium RPMI 1640 with 2% human AB serum, penicillin (100 unit/ml), streptomycin (100 unit/ml) and L-glutamine (2 mM) in the presence of 10 ug/ml phytohemagglutinin. Cell suspensions were placed by 1 ml per each well at 24 well tissue culture clusters and after 24 hours in culture at 5% CO~2~ at 37°C humidified atmosphere, cells were pelleted by centrifugation. The supernatants were stored at −70°C for future IL-2 assay.

### 3). Determination of Interleukin-2 Activity of Culture Supernatants

IL-2 activity was measured by proliferation of IL-2 dependent murine cytotoxic T cell (CTLL-2) line. Serial dilution of supernatants in RPMI 1640, supplemented with 10% human AB serum and 50 mM 2-mercaptoethanol, were incubated 20 hours with 10,000 CTLL-2 cells in a total volume of 100 ul in 96 well culture plates at 5% CO~2~ at 37°C humidified atmosphere. Cultures were pulsed after 20 hours with 1 uCi H~3~-thymidine per well and harvested 4 hours later. H~3~-thymidine (New England Nuclear, Boston, MA, USA) incorporation was measured in a Packard scintillation counter (Packard Co., Downer's Grove, IL, USA). Each value represents the mean of triplicates. IL-2 activity was calculated using standard curve obtained by 1 unit per 50% of maximum H~3~-thymidine uptake of CTLL-2 culture.

### 4). T-cell Colony forming Units

The culture method used was the agar gel system for culturing T cells using plastic petri dishes of 15×60 mm (Falcon). The agar layer in each petri dish consisted of 4 ml of medium composed of RPMI 1640 with 0.7% agarose solution and 30 minutes before using, petri dish was kept in 5% CO~2~ at 37°C humidified atmosphere. 200 ul (1.5×10^6^ cells) of lymphocytes suspension was mixed with 15 ul PHA (225 ug/ml), 15 ul HEPES (1 M) and 300 ul human AB serum. This mixture, with 1 ml 0.5% agarose solution, was permitted to gel at 24°C for 15 minutes. The dishes were incubated at 37°C in a water saturated atmosphere with 5% CO~2~. After 7 days incubation, the development of clones and their morphology were observed under an inverted microscope using a magnification of 100 X. A cell mass exceeding 15 cells was identified as a T cell colony. The total number of colonies per petri dish was calculated as an index of colony forming capacity. For each experiment, three replicate plates were scored and made a mean.

### 5). Statistical analysis

Student's unpaired t-test was used to compare mean values of normal control and of patients. All results were expressed as mean±SE.

RESULTS
=======

The IL-2 production and T cell colony forming unit of patients with chronic renal failure and the control are summarized in [Table 3](#t3-kjim-8-2-86-5){ref-type="table"}. The level of IL-2 of the normal control group was 8.8±2.2 (Mean±SE), and the level of IL-2 of the predialysis uremic, hemodialysis and CAPD groups were 3.1±0.8, 11.8±3.0 and 14.9±3.4 respectively. The level of IL-2 in the predialysis uremic group was significantly lower compared to the control, hemodialysis and CAPD groups (p\<0.05). The difference of the level of IL-2 between the control and dialytic groups was not statistically significant ([Fig. 1](#f1-kjim-8-2-86-5){ref-type="fig"}). The value of T cell colony forming unit in the control, predialysis uremic, hemodialysis and CAPD groups were 998±263, 427±69, 1114±273 and 1369±372, respectively. The value of T cell colony forming unit in the predialysis group was far lower than the other 3 groups (p\<0.05), whereas there was no significant difference between the control and either hemodialysis or CAPD group (p\>0.1).

DISCUSSION
==========

Many studies on the immunologic function of patients with chronic renal failure have showed the findings of lymphopenia^[@b16-kjim-8-2-86-5],[@b31-kjim-8-2-86-5])^, reduced cutaneous hypersensitivity to antigens^[@b6-kjim-8-2-86-5],[@b32-kjim-8-2-86-5],[@b33-kjim-8-2-86-5])^, frequent infections^[@b12-kjim-8-2-86-5],[@b34-kjim-8-2-86-5],[@b35-kjim-8-2-86-5])^, prolonged skin allograft survival^[@b7-kjim-8-2-86-5],[@b8-kjim-8-2-86-5],[@b36-kjim-8-2-86-5])^, a decreased antibody response to thyrnus derived antigen, like vaccination with HB virus^[@b8-kjim-8-2-86-5]--[@b10-kjim-8-2-86-5])^, and increased incidence of malignancies^[@b14-kjim-8-2-86-5],[@b15-kjim-8-2-86-5])^. The dominant defects in the immune system of these patients reside in the cell-mediated immunity which primarily involves T lymphocytes. Recently, using monoclonal antibodies, the T-cell subsets in the peripheral blood of uremic patients have already been examined^[@b19-kjim-8-2-86-5],[@b20-kjim-8-2-86-5],[@b37-kjim-8-2-86-5])^ and the mitogenic response of uremic lymphocytes have also been done^[@b6-kjim-8-2-86-5],[@b38-kjim-8-2-86-5]--[@b42-kjim-8-2-86-5])^. The average percent of suppressor cells in a uremic patient is normal according to some authors^[@b19-kjim-8-2-86-5],[@b20-kjim-8-2-86-5])^ and decreased according to others^[@b37-kjim-8-2-86-5],[@b43-kjim-8-2-86-5])^. Earlier studies of the in-vitro response of uremic lymphocytes to mitogens and allogeneic antigens in human patients have reported controversial results: the mitogenic responses have been variously reported as reduced^[@b6-kjim-8-2-86-5],[@b38-kjim-8-2-86-5]--[@b40-kjim-8-2-86-5],[@b44-kjim-8-2-86-5])^, normal^[@b45-kjim-8-2-86-5],[@b46-kjim-8-2-86-5])^ or even increased^[@b42-kjim-8-2-86-5])^ However, few studies were performed to measure the productivity of interleukin-2, which is a very important lymphokine produced mainly by T helper cell and T cell colony forming unit in patients with chronic renal failure.

We targeted our attention on the ability of lymphocytes to produce interleukin-2 and T cell colony formation, which is a sensitive measure of cell-mediated immunity^[@b29-kjim-8-2-86-5])^. Interleukin-2 is essential for appropriate cell cooperation in delayed type hypersensitivity reactions known to be severely impaired in patients with chronic renal failure. Lamperi and Carozzi (1985)^[@b47-kjim-8-2-86-5])^ demonstrated that the TCGF (T cell growth factor) activity was, in uremic patients in predialysis phase or on HD, reduced values in comparison to the levels observed in normal control. Kurz et al (1986)^[@b18-kjim-8-2-86-5])^ also showed that, although without statistical significance, there was a tendency by uremic peripheral blood lymphocytes to produce less IL-2 as compared to healthy controls. Beaurain et al (1989)^[@b48-kjim-8-2-86-5])^ showed again that IL-2 activity was significantly decreased in predialysis and hemodialysis uremic patients compared to healthy normal controls. But Kimmel et al (1989)^[@b49-kjim-8-2-86-5])^ reported contradictory results that all of the uremic groups (including dialytic groups) showed increased IL-2 production capacity compared to normal controls. Our results, obtained in this study, show abnormally suppressed interleukin-2 productivity in the predialysis uremic group. Dialytic groups revealed increased interleukin-2 productivity, which was even higher compared to control but statistically non-significant. Our present data are in good agreement with Lamperi and Carozzi (1985)^[@b47-kjim-8-2-86-5])^, Kurz et al (1986)^[@b18-kjim-8-2-86-5])^ and Beaurain et al (1989)^[@b48-kjim-8-2-86-5])^.

In 1976, Fibach et al^[@b27-kjim-8-2-86-5])^ showed that in-vitro colony formation with normal human lymphocytes should be of value for studies on antigenicity, the immune response and the results of virus infection and lymphocytes diseases. Colony formation with normal lymphocytes might be induced in semisolid medium by providing the appropriate antigenic stimulus. Studies with different concentrations of PHA have shown that the number of colonies formed was related to lectin concentration. T-cell colony forming cells are thought to be non-cycling small lymphocytes of a density of 1.069--1.077 g/cm^[@b3-kjim-8-2-86-5],[@b28-kjim-8-2-86-5])^. In 1989, Wakabayashi et al^[@b50-kjim-8-2-86-5])^ reported that colony formation was markedly reduced in chronic renal failure patients in comparison with normal control, with about half of the patient-group showing no colony growth. All cases showed a significant increase in colony numbers with in-vitro plasmapheresis and with the addition of exogenous interleukin-2. These results suggest that T-cell precursors exist in near normal numbers in chronic renal failure patients and that there are humoral inhibitors in the uremic plasma. Our results also showed that predialysis uremic patients revealed far lower T-cell colony forming units compared to the other 3 groups and there were no significant differences between the control and either HD or CAPD groups. These results suggest that IL-2 productivity and T-cell colony forming unit of the patients with predialysis uremic group seemed to be highly supressed compared to the control and dialytic groups. And also, dialytic treatment may be improve IL-2 productivity and the T-cell colony forming unit of the patients with predialysis uremic group.

In conclusion, the IL-2 productivity and the T-cell colony forming unit seemed to be highly suppressed in predialysis uremic patients compared to control and dialytic patients. Dialytic treatment tends to improve IL-2 productivity and T-cell colony forming unit, but further evaluations are needed to confirm these finding.
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###### 

Age and Sex Distribution of the Subjects

  Group          No. of Subjects (Male, Female)   Age        
  -------------- -------------------------------- ---------- --------
  Control        10 (9, 1)                        30.3±2.6   20--40
  Predialysis    14 (8, 6)                        36.1±2.7   21--53
  Hemodialysis   11 (6, 5)                        32.9±2.7   25--55
  CAPD           9 (7, 2)                         41.1±2.8   30--54

Values are Mean±S.E.

###### 

BUN, Creatinine, and Duration of Dialysis of the Subjects

  Group          BUN (mg/dl)   Creatinine (mg/dl)   Duration of Dialysis (month)
  -------------- ------------- -------------------- ------------------------------
  Control        14.6± 0.7     1.2±0.1              
  Predialysis    103.6±10.5    14.1±0.9             
  Hemodialysis   85.5± 8.5     13.5±1.3             25.5±5.5
  CAPD           54.9± 3.7     14.9±0.9             14.7±3.0

Values are Mean±S.E.

###### 

Interleukin-2 Productivity and T Cell Colony Forming Unit of the Patient Groups and the Control

  Group          lnterleukin-2 (Unit)                                      TCFU (Colony/Petri dish)
  -------------- --------------------------------------------------------- ---------------------------------------------------------
  Control        8.8±2.2                                                   998±263
  Predialysis    3.1±0.8[^\*^](#tfn4-kjim-8-2-86-5){ref-type="table-fn"}   427± 69[^\*^](#tfn4-kjim-8-2-86-5){ref-type="table-fn"}
  Hemodialysis   11.8±3.0                                                  1114±273
  CAPD           14.9±3.4                                                  1369±371

Values are Mean±S.E.

p\<0.05 compared to the control, hemodialysis, and CAPD groups.
